Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.

Botulinum neurotoxin serotype C (BoNT/C) is a neuroparalytic toxin associated with outbreaks of animal botulism, particularly in birds, and is the only BoNT known to cleave two different SNARE proteins, SNAP-25 and syntaxin. BoNT/C was shown to be a good substitute for BoNT/A1 in human dystonia ther...

Full description

Bibliographic Details
Main Authors: Giulia Zanetti, Stefan Sikorra, Andreas Rummel, Nadja Krez, Elisa Duregotti, Samuele Negro, Tina Henke, Ornella Rossetto, Thomas Binz, Marco Pirazzini
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-08-01
Series:PLoS Pathogens
Online Access:http://europepmc.org/articles/PMC5568444?pdf=render
_version_ 1818947162963181568
author Giulia Zanetti
Stefan Sikorra
Andreas Rummel
Nadja Krez
Elisa Duregotti
Samuele Negro
Tina Henke
Ornella Rossetto
Thomas Binz
Marco Pirazzini
author_facet Giulia Zanetti
Stefan Sikorra
Andreas Rummel
Nadja Krez
Elisa Duregotti
Samuele Negro
Tina Henke
Ornella Rossetto
Thomas Binz
Marco Pirazzini
author_sort Giulia Zanetti
collection DOAJ
description Botulinum neurotoxin serotype C (BoNT/C) is a neuroparalytic toxin associated with outbreaks of animal botulism, particularly in birds, and is the only BoNT known to cleave two different SNARE proteins, SNAP-25 and syntaxin. BoNT/C was shown to be a good substitute for BoNT/A1 in human dystonia therapy because of its long lasting effects and absence of neuromuscular damage. Two triple mutants of BoNT/C, namely BoNT/C S51T/R52N/N53P (BoNT/C α-51) and BoNT/C L200W/M221W/I226W (BoNT/C α-3W), were recently reported to selectively cleave syntaxin and have been used here to evaluate the individual contribution of SNAP-25 and syntaxin cleavage to the effect of BoNT/C in vivo. Although BoNT/C α-51 and BoNT/C α-3W toxins cleave syntaxin with similar efficiency, we unexpectedly found also cleavage of SNAP-25, although to a lesser extent than wild type BoNT/C. Interestingly, the BoNT/C mutants exhibit reduced lethality compared to wild type toxin, a result that correlated with their residual activity against SNAP-25. In spite of this, a local injection of BoNT/C α-51 persistently impairs neuromuscular junction activity. This is due to an initial phase in which SNAP-25 cleavage causes a complete blockade of neurotransmission, and to a second phase of incomplete impairment ascribable to syntaxin cleavage. Together, these results indicate that neuroparalysis of BoNT/C at the neuromuscular junction is due to SNAP-25 cleavage, while the proteolysis of syntaxin provides a substantial, but incomplete, neuromuscular impairment. In light of this evidence, we discuss a possible clinical use of BoNT/C α-51 as a botulinum neurotoxin endowed with a wide safety margin and a long lasting effect.
first_indexed 2024-12-20T08:26:32Z
format Article
id doaj.art-709a8fb2f91a4d94a1032d899d60280d
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-12-20T08:26:32Z
publishDate 2017-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-709a8fb2f91a4d94a1032d899d60280d2022-12-21T19:46:48ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742017-08-01138e100656710.1371/journal.ppat.1006567Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.Giulia ZanettiStefan SikorraAndreas RummelNadja KrezElisa DuregottiSamuele NegroTina HenkeOrnella RossettoThomas BinzMarco PirazziniBotulinum neurotoxin serotype C (BoNT/C) is a neuroparalytic toxin associated with outbreaks of animal botulism, particularly in birds, and is the only BoNT known to cleave two different SNARE proteins, SNAP-25 and syntaxin. BoNT/C was shown to be a good substitute for BoNT/A1 in human dystonia therapy because of its long lasting effects and absence of neuromuscular damage. Two triple mutants of BoNT/C, namely BoNT/C S51T/R52N/N53P (BoNT/C α-51) and BoNT/C L200W/M221W/I226W (BoNT/C α-3W), were recently reported to selectively cleave syntaxin and have been used here to evaluate the individual contribution of SNAP-25 and syntaxin cleavage to the effect of BoNT/C in vivo. Although BoNT/C α-51 and BoNT/C α-3W toxins cleave syntaxin with similar efficiency, we unexpectedly found also cleavage of SNAP-25, although to a lesser extent than wild type BoNT/C. Interestingly, the BoNT/C mutants exhibit reduced lethality compared to wild type toxin, a result that correlated with their residual activity against SNAP-25. In spite of this, a local injection of BoNT/C α-51 persistently impairs neuromuscular junction activity. This is due to an initial phase in which SNAP-25 cleavage causes a complete blockade of neurotransmission, and to a second phase of incomplete impairment ascribable to syntaxin cleavage. Together, these results indicate that neuroparalysis of BoNT/C at the neuromuscular junction is due to SNAP-25 cleavage, while the proteolysis of syntaxin provides a substantial, but incomplete, neuromuscular impairment. In light of this evidence, we discuss a possible clinical use of BoNT/C α-51 as a botulinum neurotoxin endowed with a wide safety margin and a long lasting effect.http://europepmc.org/articles/PMC5568444?pdf=render
spellingShingle Giulia Zanetti
Stefan Sikorra
Andreas Rummel
Nadja Krez
Elisa Duregotti
Samuele Negro
Tina Henke
Ornella Rossetto
Thomas Binz
Marco Pirazzini
Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.
PLoS Pathogens
title Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.
title_full Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.
title_fullStr Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.
title_full_unstemmed Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.
title_short Botulinum neurotoxin C mutants reveal different effects of syntaxin or SNAP-25 proteolysis on neuromuscular transmission.
title_sort botulinum neurotoxin c mutants reveal different effects of syntaxin or snap 25 proteolysis on neuromuscular transmission
url http://europepmc.org/articles/PMC5568444?pdf=render
work_keys_str_mv AT giuliazanetti botulinumneurotoxincmutantsrevealdifferenteffectsofsyntaxinorsnap25proteolysisonneuromusculartransmission
AT stefansikorra botulinumneurotoxincmutantsrevealdifferenteffectsofsyntaxinorsnap25proteolysisonneuromusculartransmission
AT andreasrummel botulinumneurotoxincmutantsrevealdifferenteffectsofsyntaxinorsnap25proteolysisonneuromusculartransmission
AT nadjakrez botulinumneurotoxincmutantsrevealdifferenteffectsofsyntaxinorsnap25proteolysisonneuromusculartransmission
AT elisaduregotti botulinumneurotoxincmutantsrevealdifferenteffectsofsyntaxinorsnap25proteolysisonneuromusculartransmission
AT samuelenegro botulinumneurotoxincmutantsrevealdifferenteffectsofsyntaxinorsnap25proteolysisonneuromusculartransmission
AT tinahenke botulinumneurotoxincmutantsrevealdifferenteffectsofsyntaxinorsnap25proteolysisonneuromusculartransmission
AT ornellarossetto botulinumneurotoxincmutantsrevealdifferenteffectsofsyntaxinorsnap25proteolysisonneuromusculartransmission
AT thomasbinz botulinumneurotoxincmutantsrevealdifferenteffectsofsyntaxinorsnap25proteolysisonneuromusculartransmission
AT marcopirazzini botulinumneurotoxincmutantsrevealdifferenteffectsofsyntaxinorsnap25proteolysisonneuromusculartransmission